Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | -1.61% | +1.67% | +20.79% |
Mar. 04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 04 | Passage Bio, Inc. Appoints Kathleen Borthwick as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.79% | 75.17M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.84% | 22.02B | |
-17.84% | 20.9B | |
-9.98% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Passage Bio Says Independent Panel OKs Two More Planned Cohorts in Trial of PBGM01 in GM1 Gangliosidosis